CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma

CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma

Abstract This study aims to discover the therapeutic effect of chemokine (CXC motif) receptor 4 (CXCR4) antagonist AMD3100 combined with transcatheter arterial chemoembolization (TACE) in a rat model with hepatocellular carcinoma (HCC). An orthotopic model of HCC was established and treated with T...

Full description

Bibliographic Details
Main Authors: Hong‐Wei Lei, Bi‐Run Huang, Jie Cai, Cheng‐Ming Li, Chun‐Bo Shang, Zhi‐Yang Liao, Zheng‐Dong Wan
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
AMD3100
CXCR4
hepatocellular carcinoma
transcatheter arterial chemoembolization
Online Access:https://doi.org/10.1002/kjm2.12540

Internet

https://doi.org/10.1002/kjm2.12540

Similar Items